Xeris Biopharma Holdings, Inc. earnings per share and revenue

XERS earnings per share for the last quarter are -0.11 USD whereas the estimation was -0.09 USD which accounts for -26.92% surprise. Company revenue for the same period amounts to 52.86 M USD despite the estimated figure of 51.45 M USD. Estimated earnings per share for the next quarter are -0.07 USD, and revenue is expected to reach 56.74 M USD. Also watch annual changes over time to get a bigger picture of XERS earnings per share and revenue dynamics.